Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.

Bioorg Med Chem Lett

Departments of Chemistry and Immunology, The Scripps Research Institute, La Jolla, CA 92037, United States. Electronic address:

Published: August 2017

Given the need for further improvements in anti-cocaine vaccination strategies, a chimeric hapten (GNET) was developed that combines chemically-stable structural features from steady-state haptens with the hydrolytic functionality present in transition-state mimetic haptens. Additionally, as a further investigation into the generation of an improved bifunctional antibody pool, sequential vaccination with steady-state and transition-state mimetic haptens was undertaken. While GNET induced the formation of catalytically-active antibodies, it did not improve overall behavioral efficacy. In contrast, the resulting pool of antibodies from GNE/GNT co-administration demonstrated intermediate efficacy as compared to antibodies developed from either hapten alone. Overall, improved antibody catalytic efficiency appears necessary to achieve the synergistic benefits of combining cocaine hydrolysis with peripheral sequestration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584565PMC
http://dx.doi.org/10.1016/j.bmcl.2017.07.014DOI Listing

Publication Analysis

Top Keywords

chimeric hapten
8
transition-state mimetic
8
mimetic haptens
8
augmenting efficacy
4
efficacy anti-cocaine
4
anti-cocaine catalytic
4
antibodies
4
catalytic antibodies
4
antibodies chimeric
4
hapten design
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!